267 related articles for article (PubMed ID: 18776916)
1. CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.
Zeller J; Poulsen KT; Sutton JE; Abdiche YN; Collier S; Chopra R; Garcia CA; Pons J; Rosenthal A; Shelton DL
Br J Pharmacol; 2008 Dec; 155(7):1093-103. PubMed ID: 18776916
[TBL] [Abstract][Full Text] [Related]
2. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.
Chan KY; Gupta S; de Vries R; Danser AH; Villalón CM; Muñoz-Islas E; Maassenvandenbrink A
Br J Pharmacol; 2010 Jul; 160(6):1316-25. PubMed ID: 20590623
[TBL] [Abstract][Full Text] [Related]
3. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
[TBL] [Abstract][Full Text] [Related]
4. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
5. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
Andreou AP; Holland PR; Goadsby PJ
Br J Pharmacol; 2009 Jun; 157(3):464-73. PubMed ID: 19309356
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the trigeminovascular actions of several adenosine A
Haanes KA; Labastida-Ramírez A; Chan KY; de Vries R; Shook B; Jackson P; Zhang J; Flores CM; Danser AHJ; Villalón CM; MaassenVanDenBrink A
J Headache Pain; 2018 May; 19(1):41. PubMed ID: 29802484
[TBL] [Abstract][Full Text] [Related]
7. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide as an endogenous vasodilator: immunoblockade studies in vivo with an anti-calcitonin gene-related peptide monoclonal antibody and its Fab' fragment.
Tan KK; Brown MJ; Hargreaves RJ; Shepheard SL; Cook DA; Hill RG
Clin Sci (Lond); 1995 Dec; 89(6):565-73. PubMed ID: 8549074
[TBL] [Abstract][Full Text] [Related]
9. CGRP and nitric oxide of neuronal origin and their involvement in neurogenic vasodilatation in rat skin microvasculature.
Merhi M; Dusting GJ; Khalil Z
Br J Pharmacol; 1998 Mar; 123(5):863-8. PubMed ID: 9535014
[TBL] [Abstract][Full Text] [Related]
10. CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni V; Giani L; Al-Hassany L; Asioli GM; Butera C; de Boer I; Guglielmetti M; Koniari C; Mavridis T; Vaikjärv M; Verhagen I; Verzina A; Zick B; Martelletti P; Sacco S;
J Headache Pain; 2019 Mar; 20(1):27. PubMed ID: 30866804
[TBL] [Abstract][Full Text] [Related]
11. Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
Levin M; Silberstein SD; Gilbert R; Lucas S; Munsie L; Garrelts A; Kennedy K; Everman N; Pearlman E
Headache; 2018 Nov; 58(10):1689-1696. PubMed ID: 30426478
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
13. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
14. Loss of capsaicin-induced meningeal neurogenic sensory vasodilatation in diabetic rats.
Dux M; Rosta J; Pintér S; Sántha P; Jancsó G
Neuroscience; 2007 Nov; 150(1):194-201. PubMed ID: 17920775
[TBL] [Abstract][Full Text] [Related]
15. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
Chiang CC; Schwedt TJ
Prog Brain Res; 2020; 255():143-170. PubMed ID: 33008505
[TBL] [Abstract][Full Text] [Related]
18. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.
Levy D; Burstein R; Strassman AM
Ann Neurol; 2005 Nov; 58(5):698-705. PubMed ID: 16240341
[TBL] [Abstract][Full Text] [Related]
20. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
